These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 7759846)

  • 21. [Association of orthostatic hypertension and hypotension with target organ damage in middle and old-aged hypertensive patients].
    Fan XH; Sun K; Zhou XL; Zhang HM; Wu HY; Hui RT
    Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):220-4. PubMed ID: 21418863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of aldosterone with left ventricular mass in hypertension: interaction with plasma fibrinogen levels.
    Catena C; Colussi G; Valeri M; Sechi LA
    Am J Hypertens; 2013 Jan; 26(1):111-7. PubMed ID: 23382334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation between left ventricular geometric alteration and extracardiac target organ damage in hypertensive patients.
    Ding Y; Qu P; Xia D; Wang H; Tian X
    Hypertens Res; 2000 Jul; 23(4):371-6. PubMed ID: 10912775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mediators of target organ damage in hypertension: focus on obesity associated factors and inflammation.
    Dawood T; Schlaich MP
    Minerva Cardioangiol; 2009 Dec; 57(6):687-704. PubMed ID: 19942842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease.
    Nardi E; Palermo A; Mulè G; Cusimano P; Cottone S; Cerasola G
    J Hypertens; 2009 Mar; 27(3):633-41. PubMed ID: 19262231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Post-Saline Load Plasma Aldosterone Levels With Left Ventricular Hypertrophy in Primary Hypertension.
    Catena C; Verheyen ND; Url-Michitsch M; Kraigher-Krainer E; Colussi G; Pilz S; Tomaschitz A; Pieske B; Sechi LA
    Am J Hypertens; 2016 Mar; 29(3):303-10. PubMed ID: 26163660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the hypertensive patients in southeastern Anatolia; demographic features and target organ damage.
    Aksoy H; Yılmaz R; Baş MM; Akpınar O
    Clin Exp Hypertens; 2011; 33(7):463-9. PubMed ID: 21978025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left ventricular function, haemodynamics and certain indicators of neurohumoral control during submaximal exercise in patients with essential hypertension.
    Shkhvatsabaya IK; Yurenev AP; Parfenova EV; Erina EV; Kiseleva ZM; Ustinova SE; Speranskaya NV
    Cor Vasa; 1983; 25(2):81-91. PubMed ID: 6347518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of aldosterone on the development of left ventricular geometry and hypertrophy in patients with essential hypertension.
    Soylu A; Temizhan A; Duzenli MA; Sokmen G; Koylu O; Telli HH
    Jpn Heart J; 2004 Sep; 45(5):807-21. PubMed ID: 15557722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regression of left ventricular hypertrophy in patients with hypertension.
    Balogun MO; Dunn FG
    J Hum Hypertens; 1990 Oct; 4 Suppl 4():29-32; discussion 32-4. PubMed ID: 2149391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive factors of left ventricular mass changes after treatment of primary aldosteronism.
    Catena C; Colussi GL; Marzano L; Sechi LA
    Horm Metab Res; 2012 Mar; 44(3):188-93. PubMed ID: 22351477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between urinary angiotensinogen excretion rates and left ventricular mass index and carotid intima-media thickness in hypertensive kidney transplant recipients.
    Tiryaki O; Usalan C
    Clin Transplant; 2015 Apr; 29(4):351-8. PubMed ID: 25627691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left ventricular adaptation to hypertension and plasma renin activity.
    du Cailar G; Pasquié JL; Ribstein J; Mimran A
    J Hum Hypertens; 2000 Mar; 14(3):181-8. PubMed ID: 10694832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of age on left ventricular geometric patterns in hypertensive patients.
    Sumimoto T; Mukai M; Murakami E; Kokubu T; Lin M; Shigematsu Y; Hamada M; Hiwada K
    J Hypertens; 1995 Dec; 13(12 Pt 2):1813-7. PubMed ID: 8903658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship of plasma renin, angiotensin, and aldosterone levels to blood pressure variability and target organ damage in children with essential hypertension.
    Liu Y; Lin Y; Zhang MM; Li XH; Liu YY; Zhao J; Shi L
    BMC Cardiovasc Disord; 2020 Jun; 20(1):296. PubMed ID: 32546130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. End-organ disease in hypertension: what have we learned?
    Grossman E; Messerli FH
    J Cardiovasc Pharmacol; 1992; 20 Suppl 10():S1-6. PubMed ID: 1283425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac function as related to adrenergic activity in hypertensive left ventricular hypertrophy.
    Agabiti-Rosei E; Muiesan ML; Romanelli G; Castellano M; Beschi M; Alicandri C; Muiesan G
    J Clin Hypertens; 1987 Jun; 3(2):203-10. PubMed ID: 3039076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sodium and left ventricular hypertrophy in patients with hypertension].
    du Cailar G; Mimran A
    Arch Mal Coeur Vaiss; 1995 Feb; 88 Spec No 2():15-9. PubMed ID: 7646305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular hypertrophy and hypertension: causes and consequences.
    Korner PI
    Blood Press Suppl; 1995; 2():6-16. PubMed ID: 7582077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertensive left ventricular hypertrophy risk: beyond adaptive cardiomyocytic hypertrophy.
    Frohlich ED; González A; Díez J
    J Hypertens; 2011 Jan; 29(1):17-26. PubMed ID: 21045723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.